EUPATI, the European Patients’ Academy on Therapeutic Innovation has published their Oct 2015 newsletter – learn more about the experience of students who have just completed the first Patient Xpert Training Course and why regulatory agencies think patient education and engagement are important.
- EuropaColon features a MErCuRIC patient’s perspective and our clinical trialFebruary 1, 2018 - 8:08 pm
- Reflections from EAPM 2017 where MErCuRIC PPI was HighlightedDecember 14, 2017 - 8:11 am
- EuropaColon Patients’ Survey on The Unmet Needs of Patients Living with Metastatic Colorectal CancerDecember 4, 2017 - 3:35 pm
MErCuRIC is funded by the European Community’s Framework Programme Seven (FP7) under contract #602901. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.